| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||
| High-ozonide oil—which is oil that has been ozonated to form stable ozonide compounds. • Ozone and its derivatives are highly reactive oxygen species (ROS). Some proposed theoretical mechanisms suggest that these reactive species may cause oxidative stress that could potentially lead to the death of cancer cells. • The same oxidative property, however, can also damage healthy cells and tissues if not arefully controlled, which creates concerns about therapeutic safety and side effects. thomashealthblog.com High-Ozonide Oil — High-ozonide oil is a highly ozonated vegetable oil in which ozone reacts primarily with carbon–carbon double bonds of unsaturated fatty acids to generate a complex mixture of secondary ozonides, lipid peroxides, hydroperoxides, aldehydes, carboxylic acids, and related oxidation products. It is best classified as an oxidized-lipid topical formulation rather than as a defined pharmaceutical compound. The abbreviation HOO is appropriate. Olive, sunflower, peanut, pumpkin-seed, sesame, and other unsaturated vegetable oils can be ozonated, but their resulting chemical composition differs substantially with the starting oil and ozonation conditions. “High-ozonide oil” is not a standardized pharmacological entity; peroxide value, ozonide content, starting oil, manufacturing method, and storage conditions can materially alter biological activity. Current human evidence primarily concerns topical wound healing and antimicrobial applications rather than cancer treatment. Primary mechanisms (ranked):
Bioavailability / PK relevance: Conventional pharmacokinetic parameters are poorly defined because HOO is a heterogeneous mixture rather than a single molecule. Stable ozonides and other lipid oxidation products act predominantly at the site of topical application and may decompose or react with proteins, thiols, antioxidants, membrane lipids, and water after contact with tissue. There is no established systemic anticancer dose, plasma concentration, oral bioavailability profile, or validated tumor exposure target for HOO. Composition and biological potency cannot be inferred simply from the amount of oil administered. In-vitro vs systemic exposure relevance: Published anticancer evidence is currently predominantly in vitro. For example, ozonated peanut oil inhibited colorectal carcinoma cells at low-µg/mL concentrations and ozonated pumpkin-seed oil produced cytotoxicity and early apoptosis in PC-3 prostate cancer cells. These exposures cannot presently be equated with achievable systemic tumor concentrations because systemic PK and safe systemic dosing of highly ozonated oils have not been established. Topical exposure is therefore substantially better characterized than oral, intravenous, or systemic exposure. Clinical evidence status: Cancer: preclinical/in-vitro only. There is presently no convincing randomized clinical evidence establishing HOO as a cancer treatment or cancer adjunct. Non-cancer topical use: small human studies and RCTs support wound-healing, oral-surgical, periodontal, diabetic-foot, and postoperative applications of some ozonated-oil formulations. Ozone gas itself has important inhalational toxicity and must not be conflated with stabilized ozonated oil; inhaled ozone is a pulmonary toxicant. Clinical translation of HOO is limited by formulation heterogeneity, lack of standardized ozonide/peroxide dosing, absence of systemic PK data, and lack of oncology trials. High-Ozonide Oil Cancer-Relevant Mechanisms
|
| Source: |
| Type: |
| For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream. In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects. |
| 7374- | HOO, | Exploring Ozonated Vegetable Oils as Antimicrobial and Functional Agents in Food Systems: A Systematic Narrative Review |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:334 Target#:1109 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid